Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Nashua, NH
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Summit, NJ
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Summit, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Manhasset, NY
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Norristown, PA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Norristown, PA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Nashville, TN
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Irving, TX
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Orem, UT
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Kirkland, WA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Spokane, WA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Staten Island, NY
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Boston, MA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Albany, NY
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Gainesville, FL
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Saint Petersburg, FL
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Natick, MA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Natick, MA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
Long Acting Stimulant Treatment of ADHD in Young Children
Status: Enrolling
Updated:  2/20/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
Long Acting Stimulant Treatment of ADHD in Young Children
Status: Enrolling
Updated: 2/20/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement
Lifestyle, CVD Risk, and Cognitive Impairment
Status: Enrolling
Updated:  2/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement
Lifestyle, CVD Risk, and Cognitive Impairment
Status: Enrolling
Updated: 2/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Stanford University
mi
from
Stanford, CA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Lurie Children's Hospital
mi
from
Chicago, IL
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Division of Immunology, Children's Hospital Boston
mi
from
Boston, MA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Division of Immunology, Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Status: Enrolling
Updated:  2/20/2018
University of Delaware
mi
from
Newark, DE
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Status: Enrolling
Updated: 2/20/2018
University of Delaware
mi
from
Newark, DE
Click here to add this to my saved trials
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Status: Enrolling
Updated:  2/20/2018
Alfred I. duPont Hospital for Children, Nemours
mi
from
Wilmington, DE
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Status: Enrolling
Updated: 2/20/2018
Alfred I. duPont Hospital for Children, Nemours
mi
from
Wilmington, DE
Click here to add this to my saved trials
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal
Status: Enrolling
Updated:  2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal
Status: Enrolling
Updated: 2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  2/20/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 2/20/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Massage Technique for Pain, Anxiety and Delirium in SAH Patients
Effects of Massage Technique for Pain, Anxiety, and Delirium Management in ICU Patients With Subarachnoid Hemorrhage
Status: Enrolling
Updated:  2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Massage Technique for Pain, Anxiety and Delirium in SAH Patients
Effects of Massage Technique for Pain, Anxiety, and Delirium Management in ICU Patients With Subarachnoid Hemorrhage
Status: Enrolling
Updated: 2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  2/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 2/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Treatment of Dysphagia Using the Mendelsohn Maneuver
Treatment of Dysphagia Using the Mendelsohn Maneuver
Status: Enrolling
Updated:  2/21/2018
UArkansas/UAMS Medical Center
mi
from
Little Rock, AR
Treatment of Dysphagia Using the Mendelsohn Maneuver
Treatment of Dysphagia Using the Mendelsohn Maneuver
Status: Enrolling
Updated: 2/21/2018
UArkansas/UAMS Medical Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Seizure Activity in Alzheimer's Disease
Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration
Status: Enrolling
Updated:  2/22/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Seizure Activity in Alzheimer's Disease
Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration
Status: Enrolling
Updated: 2/22/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
Evaluation of the Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy: a Pilot Study.
Status: Enrolling
Updated:  2/22/2018
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
Evaluation of the Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy: a Pilot Study.
Status: Enrolling
Updated: 2/22/2018
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Improving Functions in MTBI Patients With Headache by rTMS
Improving Functions in MTBI Patients With Headache by rTMS
Status: Enrolling
Updated:  2/23/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Improving Functions in MTBI Patients With Headache by rTMS
Improving Functions in MTBI Patients With Headache by rTMS
Status: Enrolling
Updated: 2/23/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp
Status: Enrolling
Updated:  2/23/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp
Status: Enrolling
Updated: 2/23/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated:  2/23/2018
University of Rochester
mi
from
Rochester, NY
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated: 2/23/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated:  2/27/2018
Vanderbilt University
mi
from
Nashville, TN
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated: 2/27/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Oral Immunotherapy (OIT) for Peanut Allergy
Oral Immunotherapy for Peanut Allergy- Peanut Oral Immunotherapy (PnOIT3)
Status: Enrolling
Updated:  2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Oral Immunotherapy (OIT) for Peanut Allergy
Oral Immunotherapy for Peanut Allergy- Peanut Oral Immunotherapy (PnOIT3)
Status: Enrolling
Updated: 2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
A Phase 2A, Prospective, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults Following Ischemic Stroke
Status: Enrolling
Updated:  2/27/2018
Chattanooga Center for Neurologic Research
mi
from
Chattanooga, TN
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
A Phase 2A, Prospective, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults Following Ischemic Stroke
Status: Enrolling
Updated: 2/27/2018
Chattanooga Center for Neurologic Research
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Peanut OIT & Anti-IgE: Peanut Oral Immunotherapy and Anti-IgE Treatment for Peanut Allergy {NIH R21 Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies}
Status: Enrolling
Updated:  2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Peanut OIT & Anti-IgE: Peanut Oral Immunotherapy and Anti-IgE Treatment for Peanut Allergy {NIH R21 Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies}
Status: Enrolling
Updated: 2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated:  2/27/2018
Fort Belvoir Community Hospital
mi
from
Fort Belvoir, VA
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated: 2/27/2018
Fort Belvoir Community Hospital
mi
from
Fort Belvoir, VA
Click here to add this to my saved trials
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated:  2/27/2018
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated: 2/27/2018
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Collaborative Neuroscience Network, LLC- Southland Neurologic Associates - Los Alamitos
mi
from
Garden Grove, CA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Collaborative Neuroscience Network, LLC- Southland Neurologic Associates - Los Alamitos
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
SDS Clinial Trials, Inc
mi
from
Orange, CA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
SDS Clinial Trials, Inc
mi
from
Orange, CA
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Compass Research LLC
mi
from
Orlando, FL
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials